Thursday, July 27, 6:30-8:00 p.m.
Jason Luke, MD, FACP
Assistant Professor of Medicine, Medical Oncology
The University of Chicago Medicine
Dr. Luke will review the treatment landscape for melanoma, spanning precision medicine with molecular targeted to immunotherapies, as well as the next cadre of drugs likely to receive FDA approval.